IL17RA and osteosarcoma: IL-17 can facilitate the susceptibility of osteosarcoma cells to NK cell lysis, and IL-17A/IL-17RA interaction can promote osteosarcoma cells metastasis, indicating that targeting IL-17 may be a novel promising strategy to treat osteosarcoma patients (Honorati et al., 2003; Wang et al., 2013).